Kentucky 2016 ACO
Erica Stewart
ACO Primary Contact
573-590-0250
Location
Location

AmpliPHY of Kentucky ACO LLC
4550 Montgomery Ave, Ste 950
Bethesda, MD 20814
202-803-7979

  • Advanced Internal Medicine PLLC
  • Dr. Butler & Associates, PLLC
  • Four Rivers Internal Medicine PLLC
  • GOLDENBERG & ASSOCIATES
  • James Kyle Turnbo MD PSC
  • JAMES N EICKHOLZ MD PSC
  • Jeffrey L. Riney M.D. & Associates PLLC
  • JEREMY BRADLEY
  • Kyle D. Parish, MD, PSC
  • LACROIX MEDICAL CENTER
  • Total Life Care, PLLC

No participants are involved in a joint venture between ACO professionals and hospitals

  • Turnbo, Kyle, Voting Member, 1, ACO Participant Representative, James Kyle Turnbo MD PSC
  • Lorch, Jason, Voting Member, 1, ACO Participant Representative, Four Rivers Internal Medicine PLLC
  • Riney, Jeffrey, Voting Member, 1, ACO Participant Representative, Jeffrey L. Riney MD & Associates PLLC
  • Nelson, Jennifer, Voting Member, 1, ACO Participant Representative, Total Life Care, PLLC
  • Eickholz, James, Voting Member, 1, ACO Participant Representative, James Eickholz, M.D., P.S.C
  • Butler, Danny, Voting Member, 1, ACO Participant Representative, Dr. Butler & Associates, PLLC
  • Frazine, Ryan, Voting Member, 1, ACO Participant Representative, Advanced Internal Medicine PLLC
  • Meeks, Van, Voting Member, 1, ACO Participant Representative, Total Life Care, PLLC
  • Joseph Bassi, Voting Member, 1, Medicare Beneficiary Representative, N/A
  • Parish, Kyle, Voting Member, 1,  ACO Participant Representative, Kyle. D. Parish, MD, PSC
  • Christ, Roderic, Voting Member, 1, ACO Participant Representative,  Lacroix Medical Center
  • Bradley, Jeremy, Voting Member, 1, ACO Participant Representative, Jeremy Bradley
  • Shaikh, Shabbir, Voting Member, 1, ACO Participant Representative, Goldenberg & Associates
  • Stewart, Erica, Voting Member and Chair Person, ACO Executive, Aledade, Inc., N/A
  • Executive Director: Ms. Erica Stewart
  • Medical Director: Dr. Ryan Frazine
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson
  • Compliance Committee: Dr. Danny Butler
  • Networks of individual practices of ACO professionals
  • First Agreement Period

    • Performance Year 2018, $0

    • Performance Year 2017, $0

    • Performance Year 2016, $1,110,552

First Agreement Period | Performance Year 2018 | Performance Year 2017 | Performance Year 2016

10% - Reinvest in infrastructure

30% - Invested in redesigned care processes/resources

60% - Distribution to ACO Participants

100% - Primary Care Professionals

N/A - Specialists

N/A - Hospital

2018 Quality Performance Results:
ACO#
Measure Name
Rate
ACO Mean
ACO-1
CAHPS: Getting Timely Care, Appointments, and Information
92.99
86.14
ACO-2
CAHPS: How Well Your Providers Communicate
96.42
93.93
ACO-3
CAHPS: Patients’ Rating of Provider
95.64
92.45
ACO-4
CAHPS: Access to Specialists
86.53
81.50
ACO-5
CAHPS: Health Promotion and Education
60.69
59.26
ACO-6
CAHPS: Shared Decision Making
70.63
61.94
ACO-7
CAHPS: Health Status/Functional Status
70.75
73.35
ACO-34
CAHPS: Stewardship of Patient Resources
31.88
26.26
ACO-8
Risk Standardized, All Condition Readmission
14.79
14.98
ACO-35
Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)
18.41
18.59
ACO-37
All-Cause Unplanned Admissions for Patients with Heart Failure
78.08
76.75
ACO-38
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions
63.12
59.00
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
2.68
1.98
ACO-11
Use of Certified EHR Technology
100
98.20
ACO-12
Medication Reconciliation
96.44
85.91
ACO-13
Falls: Screening for Future Fall Risk
93.44
79.73
ACO-44
Imaging Studies for Low Back Pain
77.78
64.36
ACO-14
Preventive Care and Screening: Influenza Immunization
89.29
72.71
ACO-15
Pneumonia Vaccination Status for Older Adults
93.15
75.97
ACO-16
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up
89.38
76.83
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
84.00
72.81
ACO-18
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan
93.67
66.74
ACO-19
Colorectal Cancer Screening
90.34
68.27
ACO-20
Breast Cancer Screening
92.31
71.96
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
79.85
81.47
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
10.93
15.51
ACO-41
Diabetes: Eye Exam
65.59
52.42
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
80.19
73.10
ACO-30
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
91.56
88.92
ACO-36
All-Cause Unplanned Admissions for Patients with Diabetes
36.28
37.01

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

 

Note: In the Quality Performance Results file(s) above, search for “AmpliPHY of Kentucky ACO LLC” or “Kentucky 2016 ACO” to view the quality performance results. This ACO can also be found by using the ACO ID A2809 in the public use files on data.cms.gov.

Payment Rule Waivers

Yes, our ACO does use the SNF 3-Day Rule Waiver.

  • For any feedback or complaints about the SNF 3-Day Rule Waiver, please contact:
  • Phone Number: 202-750-5867
  • Email: ky-snffeedback@aledade.com